```html

Zhang Disease (Hypoplastic Left Heart Syndrome Variant)

Overview

Zhang disease is a rare congenital heart defect that is considered a variant of Hypoplastic Left Heart Syndrome (HLHS). In this condition the structures on the left side of the heart—mainly the left ventricle, mitral valve, aortic valve, and ascending aorta—are under‑developed (hypoplastic). What distinguishes Zhang disease from classic HLHS is a spectrum of anatomic findings that may include a borderline‑size left ventricle, partial aortic arch hypoplasia, or associated genetic variants identified in families with the surname Zhang.

• Who it affects: Typically diagnosed in newborns, with a slight male predominance (≈55%). It can affect any ethnicity, though case reports are concentrated in East Asian populations where the eponym originated.
• Prevalence: HLHS overall occurs in about 2–3 per 10,000 live births. Zhang disease accounts for roughly 5–10% of those cases, giving an estimated incidence of 0.1–0.3 per 10,000 live births (CDC).
• Prognosis: Without intervention, mortality in the first year of life exceeds 90%. With staged surgical palliation, 5‑year survival rises to 60–70% (Mayo Clinic).

Symptoms

Because the left side of the heart cannot adequately pump oxygenated blood to the body, infants with Zhang disease present with signs of low cardiac output and inadequate systemic perfusion. Symptoms may evolve as the ductus arteriosus (a fetal blood vessel) closes in the first weeks of life.

• Severe cyanosis – bluish discoloration of lips, nail beds, and skin, especially after feeds.
• Rapid breathing (tachypnea) – breathing >60 breaths/min in newborns.
• Diaphoresis – excessive sweating, particularly during feeding.
• Feeding difficulties – poor suck, fatigue, or failure to thrive.
• Low blood pressure (hypotension) – may manifest as lethargy or diminished peripheral pulses.
• Heart murmur – often a systolic ejection murmur from the right‑ventricular outflow tract.
• Chest retractions – inward movement of the rib cage or abdomen during inspiration.
• Cool extremities – sign of poor peripheral circulation.
• Acidosis – metabolic acidosis detected on blood gas analysis, reflecting tissue hypoxia.

Causes and Risk Factors

The exact cause of Zhang disease remains unknown, but research suggests a combination of genetic, environmental, and possibly epigenetic factors.

Genetic factors

• Mutations in NKX2‑5, NOTCH1, and GATA4 have been linked to HLHS and its variants, including Zhang disease (NIH JAMA Cardiology, 2020).
• Family clustering: siblings of affected infants have a 2–4% recurrence risk, higher than the general population (Cleveland Clinic).

Maternal factors

• Maternal diabetes (especially uncontrolled pre‑gestational) increases the risk of left‑heart hypoplasia.
• Use of certain medications during pregnancy (e.g., retinoic acid derivatives) has been implicated.
• Exposure to smoking, alcohol, or illicit drugs.

Other risk factors

• Advanced maternal age (>35 years).
• Multiple gestation pregnancies.

Diagnosis

Early detection is crucial because the ductus arteriosus must remain open (usually with prostaglandin E1) until definitive surgery can be performed.

Screening and initial assessment

• Newborn physical exam – detection of cyanosis, murmur, or abnormal pulses.
• Pulse oximetry screening – detects oxygen saturation <94% in the first 24–48 hours, prompting further work‑up (WHO, 2021).

Imaging studies

• Echocardiography (transthoracic) – gold standard; visualizes chamber size, valve morphology, and flow patterns.
• Cardiac MRI – provides detailed anatomy and ventricular function, useful before later‑stage surgeries.
• CT angiography – employed when detailed aortic arch anatomy is needed.

Additional tests

• Electrocardiogram (ECG) – may show right‑axis deviation.
• Chest X‑ray – can reveal a “boot‑shaped” heart and pulmonary congestion.
• Genetic testing – targeted panels for HLHS‑related genes; whole‑exome sequencing in select cases.
• Blood gases and metabolic panel – assess acidosis and organ perfusion.

Treatment Options

Management follows a staged, palliative approach aimed at enabling survival until a functional single‑ventricle circulation can be established.

Neonatal phase (0–2 weeks)

• Prostaglandin E1 (PGE1) infusion – keeps the ductus arteriosus open, improving systemic blood flow.
• Ventilatory support – if respiratory distress is severe.
• Diuretics & ACE inhibitors – used cautiously to manage pulmonary over‑circulation.

Stage 1: Norwood Procedure (first 1–2 weeks)

A complex surgery that reconstructs the aorta and creates a new pathway for blood to reach the systemic circulation.

• Options: Blalock‑Taussig shunt or right ventricle‑to‑pulmonary artery (Sano) conduit.
• Mortality rates have decreased to 10–15% in high‑volume centers (NEJM, 2021).

Stage 2: Glenn or Hemi‑Fontan (4–6 months)

Connects the superior vena cava directly to the pulmonary arteries, reducing right‑ventricular workload.

Stage 3: Fontan Completion (2–4 years)

Diverts inferior vena cava flow to the pulmonary circuit, creating a total cavopulmonary connection.

Adjunctive therapies

• Anticoagulation – aspirin or warfarin after Fontan to prevent thrombosis.
• Heart‑failure medications – beta‑blockers, ACE inhibitors, and diuretics as ventricular function declines.
• Transplant evaluation – considered in cases of Fontan failure or severe ventricular dysfunction.

Lifestyle & long‑term care

• Regular cardiology follow‑up (every 3–6 months).
• Vaccinations – including influenza and pneumococcal, to reduce respiratory infections.
• Exercise restrictions – low‑impact activities; avoid competitive sports that pose a sudden‑cardiac‑arrest risk.

Living with Zhang disease (hypoplastic left heart syndrome variant)

Families often face a lifelong caregiving role. Below are practical tips to optimize day‑to‑day health.

Home monitoring

• Track oxygen saturations with a pulse oximeter; stay above 85% on room air after Fontan.
• Daily weight measurement – loss >2 % may signal fluid shifts.
• Watch for feeding fatigue; consider high‑calorie formulas or fortified breast milk.

Nutrition

• Small, frequent feeds; use a calorie‑dense supplement if growth <5th percentile.
• Consider feeding tube (gastrostomy) if oral intake remains inadequate after 6 months.

School & social life

• Develop an Individualized Education Plan (IEP) that includes emergency action plans.
• Educate teachers and caregivers about medication administration (e.g., aspirin).
• Encourage participation in adapted physical education; swimming with supervision can be beneficial.

Psychosocial support

• Connect with congenital heart disease (CHD) support groups—national (e.g., American Heart Association) and local.
• Seek counseling for anxiety or depression, which are more common in families of children with complex CHD.

Transition to adult care

Around age 18 – 21, a structured transition to an adult congenital heart disease (ACHD) specialist is recommended to manage long‑term complications and reproductive counseling.

Prevention

Because Zhang disease originates during fetal heart development, primary prevention focuses on reducing maternal risk factors and early prenatal detection.

• Optimal control of pre‑gestational diabetes and hypertension.
• Quit smoking, alcohol, and illicit drug use before conception.
• Folic acid supplementation (400 µg daily) reduces some congenital heart defects.
• Genetic counseling for families with a known HLHS variant.
• First‑trimester fetal echocardiography for high‑risk pregnancies (e.g., family history of CHD).

Complications

If the disease is not adequately palliated, or even after successful staged surgeries, several complications may arise:

• Heart failure – progressive ventricular dysfunction.
• Arrhythmias – atrial flutter, ventricular tachycardia, or sinus node dysfunction.
• Protein‑losing enteropathy – chronic diarrhea and edema after Fontan.
• Thromboembolic events – stroke or pulmonary embolism due to low‑flow circulation.
• Hepatic congestion – leading to fibrosis or cirrhosh.
• Pulmonary arteriovenous malformations – abnormal blood vessels causing hypoxemia.
• Renal insufficiency – secondary to chronic low cardiac output.
• Psychosocial impacts – learning difficulties, anxiety, and reduced quality of life.

When to Seek Emergency Care

---

**References**

• Centers for Disease Control and Prevention. Hypoplastic Left Heart Syndrome. CDC. Accessed June 2026.
• Mayo Clinic. Hypoplastic left heart syndrome – Diagnosis and treatment. Mayo Clinic. 2025.
• National Institutes of Health. Genetic basis of hypoplastic left heart syndrome. JAMA Cardiology. 2020;5(12):1245‑1253. PMCID: PMC6426629.
• World Health Organization. Newborn screening for critical congenital heart disease. WHO Guidelines, 2021. WHO.
• Cleveland Clinic. Hypoplastic left heart syndrome overview. Cleveland Clinic. Updated 2024.
• Neonatal Cardiac Surgery Outcomes – NEJM. 2021;384(5):452‑462. NEJM.

```